METIS THERAPEUTICS
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.
METIS THERAPEUTICS
Industry:
Biopharma Biotechnology Genetics Health Care Machine Learning
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.metistx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
176.22 M USD
Similar Organizations
Rubix LS
Rubix LS primary goal is to eradicate rare diseases through transformative research and development, breakthroughs in engineering.
Rheos Medicines
A biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease.
Renova Therapeutics
Renova Therapeutics is an industry leader in the emerging field of gene therapy, pursuing the development of treatments.
Receptos
Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.
ReviR Therapeutics
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Nereid Therapeutics
Nereid Therapeutics is discovering new disease treatments by applying research and technologies in biomolecular condensates.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Nodexus
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
VistaPath Biosystems
VistaPath Biosystems develops a tissue grossing platform that automates the process of inspecting, inking, and measuring tissues.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Vascular Pharmaceuticals
Vascular Pharmaceuticals is a drug discovery company developing monoclonal antibody treatments for diabetic nephropathy.
Valisure
Valisure is a digital pharmacy to chemically validate medications for quality and consistency.
Mytide Therapeutics
Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.
Memo Therapeutics
Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.
Libero Thera
Libero Thera provides drug discovery research and development services.
LPATH
Lpat focuses on the discovery and development of monoclonal antibodies that target bioactive lipids.
LUCA Biologics
Live biotherapeutics targeting the vaginal microbiome for unmet medical needs in urogenital and reproductive health.
Ariel Precision Medicine
Ariel Precision Medicine medicine solutions for diagnosis, monitoring, and treatment of diseases and disorders.
Antera Therapeutics
Antera Therapeutics is creating therapies that will prevent allergy development in children.
Adendra Therapeutics
Adendra Therapeutics wants to use new insights into dendritic cell biology to develop a novel type of immunotherapy.
Artizan Biosciences
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.
AnTolRx
Our lead program addresses significant unmet needs in the field of Type 1 Diabetes
Anivive
Anivive is focuses on reshaping pet healthcare by bringing together experts in software development, veterinary & clinical research.
Apostle
Apostle Inc is a provider of innovative technologies and services for public health and life sciences.
ExcepGen
ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.
Eton Pharmaceuticals
Eton Pharmaceuticals develops proprietary formulations of approved molecules in ways that offer improvements for patients and physicians.
EGenesis
EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.
Epic Therapeutics
Epic Therapeutics, Inc. operates as a drug delivery company.
BioNex Solutions
BioNex Solutions develops advanced laboratory automation systems for applications in biopharmaceutical, biotech and academic research.
Bionaut Labs
Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.
The ODIN
The ODIN provides kits and tools that helps consumers make organisms at home.
Torigen Pharmaceuticals
Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.
Tavotek Biotherapeutics
Tavotek Biotherapeutics focused on discovering, acquiring, developing, and commercializing therapeutic medicines.
Juvena Therapeutics
Juvena Therapeutics is a biopharmaceutical platform which is discovering novel protein-based therapeutics.
Quartet Medicine
Quartet Medicine is discovering and developing novel treatments
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
SHINEKING BIOTECH
SHINEKING BIOTECH specializes in the research and development and production of bio polymers.
SanaRx Biotherapeutics
SanaRx Biotherapeutics is designed to improve detection, visualization and treatment of 3 rare diseases.
Switchback Systems
Switchback Systems is an early stage startup working to democratize DNA synthesis.
SparX Group
SparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates.
Deciduous Therapeutics
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.
Dyve Biosciences
Dyve creates novel therapeutics using proprietary science that leverages the skin as a portal for systemic delivery.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Humane Genomics
Humane Genomics is a virus development platform that develops artificial viruses to cure diseases.
I Peace
I Peace, Inc. is a CDMO specializing in iPSC-derived cell products. We provide cGMP manufacturing service and personal iPSC banking service.
Idorsia
The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
ImmuneOnco Biopharma
ImmuneOnco is a tumor immunotherapy product developer engaged in the development and research of tumor immunotherapy products.
Gameto
Gameto is a biotechnology firm focused on female reproductive fertility biotech.
Gemini Therapeutics
Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.
Gaba Therapeutics
Gaba Therapeutics is a therapeutic company that develops anxiety medications.
Omega Therapeutics
Omega Therapeutics offers a proprietary epigenomic programming platform.
OneThree Biotech
OneThree Biotech redesigns drug discovery with biology-driven artificial intelligence.
Orreco
Orreco provides biomarker analysis for athletes, federations, and professional franchises.
Ovid Therapeutics
Ovid Therapeutic's purpose is to solve intractable medical problems.
Ona Therapeutics
Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer.
Odyssey Therapeutics
Odyssey Therapeutics provides medicines to patients with inflammatory diseases and cancer.
3T Biosciences
3T Biosciences is an immunotherapy company headquartered in Menlo Park, California.
Coordination Pharmaceuticals
Coordination Pharmaceuticals is a drug development company that aims to address unmet medical needs and improve patient care.
Cerecor
Cerecor discovers, develops and commercializes neuroscience drugs.
Chamishi Therapeutics
Chamishi Therapeutics is a drug discovery and development company focused on neurodegenerative diseases and other related disorders.
Canopy Biosciences
Canopy Biosciences aims to accelerate the commercialization of life science reagent tools and services through in-licensing.
Clade Therapeutics
Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.
Cardiol Therapeutics
Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
CRISPR Therapeutics
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Cleave Therapeutics
Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.
Psy Therapeutics
Psy Therapeutics is discovering and developing novel medicines to improve the lives of people affected by central nervous system disorders.
Current Employees Featured
Founder
Investors List
5Y Capital
5Y Capital investment in Series B - METiS Therapeutics
Lightspeed China Partners
Lightspeed China Partners investment in Series B - METiS Therapeutics
Monolith Management
Monolith Management investment in Series B - METiS Therapeutics
FREES FUND
FREES FUND investment in Series B - METiS Therapeutics
CMB International Capital Corporation
CMB International Capital Corporation investment in Series B - METiS Therapeutics
PICC Capital Investment Management
PICC Capital Investment Management investment in Series B - METiS Therapeutics
China Life Private Equity Investment
China Life Private Equity Investment investment in Series B - METiS Therapeutics
Sequoia Capital China
Sequoia Capital China investment in Series B - METiS Therapeutics
Lightspeed China Partners
Lightspeed China Partners investment in Series A - METiS Therapeutics
Picc Group
Picc Group investment in Series A - METiS Therapeutics
Official Site Inspections
http://www.metistx.com Semrush global rank: 7.27 M Semrush visits lastest month: 548
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "METiS Therapeutics"
METiS Therapeutics | AI drug discovery
METiS focuses on leveraging Artificial Intelligence (AI), Machine Learning (ML), and Molecular Dynamics (MD) to develop novel therapeutics in the small molecule, biologics, and advanced …See details»
Scientist II, Computer Aided Drug Design - METiS Therapeutics
METiS is founded by an enthusiastic team of MIT researchers and serial entrepreneurs. Our cross-disciplinary expertise and deep industry experiences allow METiS to harness AI to …See details»
Director, R&D Project Management | METiS Therapeutics
Through the integration of machine learning, quantum simulation, and high-throughput experimentation, we enable scientists to rapidly, comprehensively, and intelligently develop …See details»
METiS Therapeutics - Crunchbase Company Profile
Dec 7, 2021 · METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation. A method for …See details»
METiS Therapeutics - LinkedIn
Redefining drug discovery and delivery with a data-driven platform to develop best-in-class treatments | The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism-...See details»
METiS Therapeutics Launches With $86 Million Series A …
Dec 7, 2021 · METiS Therapeutics is a biotechnology company that aims to drive best-in-class therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning,...See details»
METiS Joins the Roche Accelerator - Business Wire
May 18, 2022 · METiS is a biotechnology company that aims to drive best-in-class therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine …See details»
METiS Announces License Agreement with Evopoint …
Jan 6, 2023 · Under the terms of the collaboration, METiS will receive an exclusive, worldwide, royalty-bearing license to develop and commercialize Evopoint’s SOS1 inhibitor program, a key regulatory...See details»
Director, CMC - METiS Therapeutics
METiS Therapeutics Inc is a biotechnology company with a unique technology platform that has the potential to drive best-in class drug assets in a wide range of therapeutic areas.See details»
METiS Therapeutics Appoints Hongming Chen, Sc.D., President
Jan 20, 2022 · METiS Therapeutics is a biotechnology company that aims to drive best-in-class therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, …See details»
METiS Therapeutics Launches With $86 Million Series A Financing …
Dec 7, 2021 · METiS Therapeutics is a biotechnology company that aims to drive best-in-class therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, …See details»
METiS Therapeutics Appoints Hongming Chen, Sc.D ... - Business …
Jan 20, 2022 · METiS Therapeutics is a biotechnology company that aims to drive best-in-class therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, …See details»
METiS Announces License Agreement with Evopoint Biosciences
Jan 6, 2023 · Under the terms of the collaboration, METiS will receive an exclusive, worldwide, royalty-bearing license to develop and commercialize Evopoint’s SOS1 inhibitor program, a …See details»
Sr / Principal Scientist, Medicinal Chem | METiS Therapeutics
METiS is founded by an enthusiastic team of MIT researchers and serial entrepreneurs. Our cross-disciplinary expertise and deep industry experiences allow METiS to harness AI to …See details»
METiS Announces Pan-RAF Inhibitor License Agreement with …
Sep 13, 2022 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Metis Therapeutics, a Boston-area company integrating drug discovery and delivery with AI and machine learning, today …See details»
METiS Therapeutics Inc. | Insights
Jul 7, 2024 · Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Director, Artificial intelligence (AI) | METiS Therapeutics
METiS is founded by an enthusiastic team of MIT researchers and serial entrepreneurs. Our cross-disciplinary expertise and deep industry experiences allow METiS to harness AI to …See details»
METiS Announces Pan-RAF Inhibitor License Agreement with …
Sep 13, 2022 · Under the terms of this license agreement, METiS will receive exclusive license to develop and commercialize Voronoi’s pan-RAF inhibitor program worldwide. In exchange, …See details»
What is a matrix organization and how does it work? - Asana
Feb 22, 2024 · What is a matrix organization and how does it work? A matrix organization is a company structure where teams report to multiple leaders. The matrix design keeps open …See details»
JOIN US - METiS Therapeutics
Join the team for an excited career in therapeutics for AI drug discovery.See details»